TSX Trading Suspended – Acerus Pharmaceuticals Corporation (ASP)

January 26, 2023
Issuer: Acerus Pharmaceuticals Corporation
Security: Common Shares (the "Shares")
Symbol(s): ASP
Delisting Review Type: Expedited
Reason: TSX is reviewing the Shares with respect to meeting the requirements for continued listing pursuant to the Expedited Review Process.
Trading: The Shares are suspended from trading immediately.
TSX contact: Selma Thaver,
TSX Listings